Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Diagnostic Hybrids
Athens, Ohio, United Statesquidelortho.com ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
Prior to its acquisition in early 2010 by Quidel Corporation for $130 million, Diagnostic Hybrids was a profitable and rapidly growing manufacturer of direct fluorescent antibody in vitro diagnostic assays. Its products were widely used in hospital and reference laboratories for the detection of viral respiratory infections—including influenza A/B—herpes viruses, chlamydia, and thyroid diseases. The company reported $51 million in revenue for FY2009 with strong growth driven by demand during the H1N1 pandemic[2][7].
- Therapeutic areas
- EndocrinologyInfectious Diseases
- Modalities
- Device (diagnostic kits)Antibody (for direct fluorescent assays)Cell culture-based diagnosticsMolecular diagnostic kit (limited)
- Industry
- Protein Biomarker Diagnostics
02
Partnerships
Licensed technology from Case Western Reserve University[6]
Beyond the preview
Go deeper on Diagnostic Hybrids.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Diagnostic Hybrids.